Acute lymphoblastic leukemia.


Journal Article

The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multi-disciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.

Full Text

Cited Authors

  • Alvarnas, JC; Brown, PA; Aoun, P; Ballen, KK; Bellam, N; Blum, W; Boyer, MW; Carraway, HE; Coccia, PF; Coutre, SE; Cultrera, J; Damon, LE; DeAngelo, DJ; Douer, D; Frangoul, H; Frankfurt, O; Goorha, S; Millenson, MM; O'Brien, S; Petersdorf, SH; Rao, AV; Terezakis, S; Uy, G; Wetzler, M; Zelenetz, AD; Naganuma, M; Gregory, KM; National Comprehensive Cancer Network,

Published Date

  • July 2012

Published In

Volume / Issue

  • 10 / 7

Start / End Page

  • 858 - 914

PubMed ID

  • 22773801

Pubmed Central ID

  • 22773801

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2012.0089


  • eng